All articles by Hemanth Kumar
Hemanth Kumar
IDgenetix test shows increase in medication response and remission in study
The study showed that the test improved care of patients with moderate to severe depression.
Revamp closes funding to support clinical programme for Doraya catheter
The company will continue clinical trials to evaluate the efficacy of the Doraya temporary venous catheter system.
QuantalX secures breakthrough device status for Delphi-MD
The breakthrough status was granted for diagnosis of normal pressure hydrocephalus patients and prediction of response to VPS.
Blue Earth Diagnostics receives FDA approval for Posluma injection
The radioactive diagnostic agent is indicated for PET of PSMA-positive lesions in men with prostate cancer.
LG Electronics launches new diagnostic monitor with IPS Black panel
The 32HQ713D monitor provides sharp and clear images with deeper blacks.
Guardant Health secures approval for liquid biopsy test in Singapore
The Guardant360 CDx CGP blood test facilitates personalised treatment decisions for patients with advanced solid cancers.
Sanofi study shows Dario solution reduces healthcare resource utilisation
The study demonstrated a 9.3% reduction in all-cause healthcare resource utilisation rates in Dario users, compared to non-users.
MaximBio receives contract from NIH to develop new rapid test platform
The company will develop a Covid-19 and Influenza A/B combo test that will employ lateral-flow assay (LFA) technology.
Thermo Fisher and Pfizer to enhance access to NGS testing for cancer
The companies intend to increase the availability of NGS-based testing for cancer patients.
Sernova and AstraZeneca team to study novel therapeutic cell applications
The two companies will assess the feasibility of potential therapeutic applications and subsequent product development.